Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions

Berglind O Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, Henrik Jespersen, Jan Mattsson, Lisa M Nilsson, Katarina Truvé, Marcela Dávila López, Peter Naredi, Ola Nilsson, Ulrika Stierner, Lars Ny, Jonas A Nilsson

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Abstract

The development of novel therapies against melanoma would benefit from individualized tumor models to ensure the rapid and accurate identification of biomarkers of therapy response. Previous studies have suggested that patient-derived xenografts (PDXes) could be useful. However, the utility of PDXes in guiding real-time treatment decisions has only been reported in anecdotal forms. Here tumor biopsies from patients with stage III and IV metastatic malignant melanoma were transplanted into immunocompromised mice to generate PDXes. 23/26 melanoma biopsies generated serially transplantable PDX models, and their histology, mutation status and expression profile resembled their corresponding patient biopsy. The potential treatment for one patient was revealed by an in vitro drug screen and treating PDXes with the MEK inhibitor trametinib. In another patient, the BRAF mutation predicted the response of both the patient and its corresponding PDXes to MAPK-targeted therapy. Importantly, in this unselected group of patients, the time from biopsy for generation of PDXes until death was significantly longer than the time required to reach the treatment phase of the PDXes. Thus, it could be clinically meaningful to use this type of platform for melanoma patients as a pre-selection tool in clinical trials.

Original languageEnglish
Pages (from-to)9609-18
Number of pages10
JournalOncotarget
Volume5
Issue number20
DOIs
Publication statusPublished - 30 Oct 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions'. Together they form a unique fingerprint.

Cite this